Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IPOPEMA SecuritiesLTS:0MMY 57 Days Payable is 506.81 as of Mar. 2026, which is 15% above its 10-year median of 439.24. GuruFocus rates LTS:0MMY with a GF Score™ of 57/100 and a GF Value™ of zł0.93. The stock has 8 warning signs investors should review. Among 539 Capital Markets companies, IPOPEMA Securities ranks better than 73.1% on this metric.
The historical rank and industry rank for IPOPEMA Securities's Days Payable or its related term are showing as below:
LTS:0MMY'
s Days Payable Range Over the Past 10 Years
Min: 249.01 Med: 439.24 Max: 1010.72
Current: 510.04
During the past 13 years, IPOPEMA Securities's highest Days Payable was 1010.72. The lowest was 249.01. And the median was 439.24.
LTS:0MMY's Days Payable is ranked better than 73.1% of 539
companies
in the Capital Markets industry
Industry Median: 88.46
vs LTS:0MMY: 510.04
IPOPEMA Securities's Days Payable
increased
from Mar. 2025 (351.56) to Mar. 2026 (506.81).
It may suggest that IPOPEMA Securitiesdelayed paying its suppliers.
IPOPEMA Securities Days Payable Related Terms
IPOPEMA Securities Days Payable Historical Data
* Premium members only.
The historical data trend for IPOPEMA Securities's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Capital Markets subindustry, IPOPEMA Securities's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IPOPEMA Securities Days Payable vs Capital Markets Industry
For the Capital Markets industry and Financial Services sector, IPOPEMA Securities's Days Payable distribution charts can be found below:
* The bar in red indicates where IPOPEMA Securities's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
IPOPEMA Securities's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IPOPEMA Securities (LTS:0MMY) has a Days Payable of 506.81 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on IPOPEMA Securities and its competitors. This is 15% above median its historical median of 439.24. Over the past decade, IPOPEMA Securities' Days Payable has ranged from 249.01 to 1,010.72. According to the industry distribution chart, IPOPEMA Securities ranks #145 out of 539 companies in the Capital Markets industry, placing it in the top 26.9%.
Is IPOPEMA Securities' Days Payable too high?
IPOPEMA Securities' current Days Payable of 506.81 is 15% above median its 10-year median of 439.24. Over the past 10 years, this metric has ranged from a low of 249.01 to a high of 1,010.72. The Capital Markets industry median Days Payable is 88.46. IPOPEMA Securities' value of 506.81 is 472.9% above this industry median. Based on the distribution chart, IPOPEMA Securities ranks #145 out of 539 companies in the Capital Markets industry, which is above the industry midpoint. Overall, IPOPEMA Securities has a GF Score™ of 57/100, reflecting its overall financial health beyond just this single metric.
How does IPOPEMA Securities' Days Payable compare to MS and GS?
According to the Capital Markets industry distribution chart, IPOPEMA Securities ranks #145 out of 539 companies for Days Payable. This puts IPOPEMA Securities in the upper half of its industry. The industry median Days Payable is 88.46. IPOPEMA Securities' value of 506.81 is 472.9% above this benchmark. Historically, IPOPEMA Securities' own Days Payable has ranged from 249.01 to 1,010.72 over the past decade. While the company's 10-year median is 439.24 vs. the industry median of 88.46, IPOPEMA Securities has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Capital Markets company?
The median Days Payable among Capital Markets companies is 88.46, based on 539 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IPOPEMA Securities's current Days Payable of 506.81 is 472.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on IPOPEMA Securities and its competitors. For the Capital Markets industry, the median Days Payable is 88.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IPOPEMA Securities's current Days Payable is 506.81, which is 15% above median its own 10-year median of 439.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IPOPEMA Securities stock overvalued right now?
IPOPEMA Securities (LTS:0MMY) has a current Days Payable of 506.81. The stock's GF Value™ is zł0.93, compared to a current price of zł1.90 — trading 104.3% above its estimated fair value. The current Days Payable is 506.81, which is 15% above median its 10-year median of 439.24 and 472.9% above the Capital Markets industry median of 88.46. IPOPEMA Securities' overall GF Score™ is 57/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For IPOPEMA Securities (LTS:0MMY), the current Days Payable is 506.81 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IPOPEMA Securities (LTS:0MMY) Overvalued in 2026?
Based on GuruFocus' analysis, IPOPEMA Securities stock appears to be overvalued.
The current stock price of zł1.90 is trading 104.3% above its estimated GF Value™ of zł0.93.
Key valuation signals for LTS:0MMY:
Days Payable: 506.81 (15% above median its 10-year median of 439.24)
GF Value™: zł0.93 vs. price of zł1.90 (104.3% above fair value)
Industry Position: 472.9% above the Capital Markets median (#145 of 539)
No single metric tells the full story. See the LTS:0MMY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IPOPEMA Securities SA is focused on brokerage activities, Business and management consulting, running an investment fund company and creating and managing investment funds, Management of portfolios of brokerage financial instruments, IT management activities, and IT consulting activities. It specializes in brokerage and company analysis services, investment banking services, as well as the distribution of investment products and investment advisory services addressed to a wide range of individual investors, the creation and management of closed-end and open-end investment funds and asset management, as well as business and IT consulting services.
57GF Score
Get the complete analysis for LTS:0MMY
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0MMY has been successfully added to your 
